| Literature DB >> 32494763 |
Fatemeh Moradi1, Akram Ghadiri-Anari2, Ali Dehghani3, Seyed Reza Vaziri4, Behnaz Enjezab5.
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic disorders known with irregular menstruation, hirsutism, alopecia, obesity, infertility, and acne. These symptoms cause a negative effect on the satisfaction of body image, self-esteem, and quality of life in such patients. Recent studies emphasize the need to consider the psychological problems in these women and also the need for appropriate interventions.Entities:
Keywords: Body image; Cognitive behavior therapies.; Polycystic ovary syndrome; Self-esteem; Acceptance and commitment therapy
Year: 2020 PMID: 32494763 PMCID: PMC7218668 DOI: 10.18502/ijrm.v13i4.6887
Source DB: PubMed Journal: Int J Reprod Biomed ISSN: 2476-3772
The content of sessions based on ACT
|
| |
|
|
|
|
| |
|
| Pretest, patients' introduction and review of the aims of sessions |
|
| Teaching the concepts of acceptance and commitment, creating insight into the problem, and challenging the control |
|
| Creating creativity from hopelessness and talk about discomforts and problems that participants have been trying to get rid of |
|
| Creating acceptance and mindfulness by abandoning attempts to control and teaching the diffusion techniques, reviewing the previous session's homework |
|
| Teaching lives based on values and choice, reviewing the previous session's homework |
|
| Assessment of aims, validation of values, purposes, and actions and obstacles to them |
|
| Assessment of values, aims and acts, engagement with eagerness and commitment |
|
| Identification and removal of obstacles to commitment actions, conclusion, post-test (13, 14) |
Baseline characteristics on subjects in the intervention and control groups
|
| ||||
|
|
|
|
| |
|
| ||||
|
| ||||
|
| 7 (26.9) | 10 (38.5) | ||
|
| 19 (73.1) | 16 (61.5) | <brow>-2</erow> 0.47 | |
|
| ||||
|
| 13 (50) | 8 (30.8) | ||
|
| 13 (50) | 18 (69.2) | <brow>-2</erow> 0.15 | |
|
| ||||
|
| 16 (61.5) | 21 (80.8) | ||
|
| 10 (38.5) | 5 (19.2) | <brow>-2</erow> 0.12 | |
|
| ||||
|
| 5 (31.2) | 9 (42.9) | 0.20 | |
|
| 11 (68.8) | 12 (57.1) | ||
|
| ||||
|
| 6 (37.5) | 6 (28.6) | 0.56 | |
|
| 10 (62.5) | 15 (71.4) | ||
|
| ||||
|
| 16 (61.5) | 21 (80.8) | 0.12 | |
|
| 10 (38.5) | 5 (19.2) | ||
|
| ||||
|
| 21 (80.8) | 21 (80.8) | 1.0 | |
|
| 5 (19.2) | 5 (19.2) | ||
|
| ||||
|
| 19 (73.1) | 18 (69.2) | 0.76 | |
|
| 7 (26.9) | 8 (30.8) | ||
|
| ||||
|
| 10 (38.5) | 11 (42.3) | 0.77 | |
|
| 16 (61.5) | 15 (57.7) | ||
|
| ||||
|
| 9 (34.6) | 7 (26.9) | 0.54 | |
|
| 17 (65.4) | 19 (73.1) | ||
|
| ||||
|
| 15 (57.7) | 16 (61.5) | 0.77 | |
|
| 11 (42.3) | 10 (38.5) | ||
| Data presented as frequency (%); *Chi-square test | ||||
Comparison of mean scores of body image concern and self-esteem and its changes before the intervention, after the intervention, and follow-up in two groups
|
| ||||
|
|
|
|
| |
|
| ||||
|
| ||||
|
| 40.84 | 44.07 | 0.32 | |
|
| 37.04 | 44.46 | 0.03 | |
|
| 36.22 | 43.60 | 0.03 | |
|
| 0.001** | 0.105** | ||
|
| ||||
|
| 28.34 | 29.11 | 0.55 | |
|
| 31.82 | 29.42 | 0.05 | |
|
| 30.59 | 30.73 | 0.92 | |
|
|
| 0.006** | ||
| Data presented as Mean | ||||